Legal Opinion
Baxter Healthcare Corp. v. HQ Specialty Pharma Corp.
District Court, D. New Jersey
Decided September 23, 2015No. Civil Action No. 13-6228 (JBS/KMW)PublishedCited by 6 opinions
1Opinion of the Court
OPINION
SIMANDLE, Chief Judge:
1. INTRODUCTION
In this infringement litigation under the Hatch-Waxman Act, 35 U.S.C. §§ 271, 282, Plaintiffs Baxter Healthcare Corporation, Baxter International Inc., and Baxter Healthcare S.A. (collectively, “Baxter”) allege that Defendant HQ Specialty Pharma Corporation’s (hereinafter, “HQ”) proposed generic esmolol hydrochloride product infringes the composition and method of manufacture patents for Baxter’s esmo-lol hydrochloride product, U.S. Patent Nos. 6,310,094 (hereinafter, “'094 Patent”) and 6,528,540 (hereinafter, “'540 Patent” and collectively, the…
2Cases cited41 opinions
- Scott v. HarrisSupreme Court of the United States · 2007
- MARKMAN Et Al. v. WESTVIEW INSTRUMENTS, INC., Et Al.Supreme Court of the United States · 1996
- Edward H. Phillips v. Awh Corporation, Hopeman Brothers, Inc., and Lofton Corporation, Defendants-CrossCourt of Appeals for the Federal Circuit · 2006
- Herbert Markman and Positek, Inc. v. Westview Instruments, Inc. And Althon Enterprises, Inc.Court of Appeals for the Federal Circuit · 1995
- Vitronics Corporation v. Conceptronic, Inc.Court of Appeals for the Federal Circuit · 1996
36 more not listed; retrieve them via the Exa API.
3Cited by6 opinions
- Baxter Healthcare Corp. v. HQ Specialty Pharma Corp.District Court, D. New Jersey · 2016
- Smart Vent, Inc. v. USA Floodair Vents, Ltd.District Court, D. New Jersey · 2016
- Otsuka Pharmaceutical Co. v. Torrent Pharmaceuticals Ltd.District Court, D. New Jersey · 2015
- Baxter Healthcare Corp. v. Mylan Labs. Ltd.District Court, D. New Jersey · 2016
- CHIESI USA, INC. v. MSN PHARMACEUTICALS INC.District Court, D. New Jersey · 2021
1 more not listed; retrieve them via the Exa API.